Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Keteling preparation for treating hepatitis B

A technology for hepatitis B and ketamine, which is applied in the directions of antiviral agents, medical preparations containing active ingredients, plant raw materials, etc.

Inactive Publication Date: 2020-05-01
GUANGDONG LUOFUSHAN SINOPHARM
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, it has not been found that the combination of Ficus microphylla and chlorpheniramine maleate according to specific content can treat hepatitis B

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Keteling preparation for treating hepatitis B

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] An example of the application of Ketelin of the present invention in the preparation of drugs for the treatment of hepatitis B, said Ketelelin in this embodiment comprises the following components by weight: 100 parts of dry extract of Ficus lobata, Chlorpheniramine 0.2 part.

[0021] In the present embodiment, the said Ketraline can be mixed with different excipients to make various oral solid dosage forms such as tablets, capsules, granules, and pellets. The excipients can be selected from pharmaceutically acceptable excipients according to the prior art, and conventional methods of the prior art are also used for the preparation of various dosage forms. The mass percentage content of said Ketraline in said medicine is 60-95%, which can be reasonably adjusted and selected according to different dosage forms.

Embodiment 2

[0023] An embodiment of the application of Ketelilin in the preparation of medicines for treating hepatitis B of the present invention, said Ketelilin in this embodiment comprises the following components by weight: 280 parts of dry extract of Ficus lobata, 1.8 parts of chlorpheniramine.

[0024] In the present embodiment, the said Ketraline can be mixed with different excipients to make various oral solid dosage forms such as tablets, capsules, granules, and pellets. The excipients can be selected from pharmaceutically acceptable excipients according to the prior art, and conventional methods of the prior art are also used for the preparation of various dosage forms. The mass percentage content of said Ketraline in said medicine is 60-95%, which can be reasonably adjusted and selected according to different dosage forms.

Embodiment 3

[0026] An embodiment of the application of Ketelin of the present invention in the preparation of medicines for treating hepatitis B, said Ketelelin in this embodiment comprises the following components in parts by weight: 130 parts of dry extract of Ficus lobata, Chlorpheniramine 0.5 part.

[0027] In the present embodiment, the said Ketraline can be mixed with different excipients to make various oral solid dosage forms such as tablets, capsules, granules, and pellets. The excipients can be selected from pharmaceutically acceptable excipients according to the prior art, and conventional methods of the prior art are also used for the preparation of various dosage forms. The mass percentage content of said Ketraline in said medicine is 60-95%, which can be reasonably adjusted and selected according to different dosage forms.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of Keteling to preparation of medicines for treating hepatitis B. The Keteling comprises the following components in parts by weight of 100-300 parts of ficus microcarpa extracta sicca, and 0.2-2 parts of maleic acid chlorpheniramine. According to the application disclosed by the invention, the Keteling has a new application for treating the hepatitis B, anda new medicine selection is provided for the treatment of the hepatitis B.

Description

technical field [0001] The present invention relates to a new use of a Keteride preparation, especially a use of a Keteride preparation in treating hepatitis B. Background technique [0002] Viral hepatitis B, referred to as hepatitis B, is a disease caused by hepatitis B virus (HBV), mainly inflammatory lesions of the liver, and can cause multiple organ damage. The harm of hepatitis B is huge. Long-term replication of hepatitis B virus may lead to serious consequences such as liver fibrosis, liver cirrhosis, liver ascites, and liver cancer. [0003] Hepatitis B is an infectious disease with a higher incidence rate. Especially in my country, there are more than 100 million hepatitis B patients and virus carriers, accounting for about 10% of the total population of the country. In some high-incidence areas, B Hepatitis patients reach more than 70%. Hepatitis B treatment mainly includes anti-HBV treatment, improving immunity, anti-inflammatory and liver protection, among whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/60A61K31/4402A61P1/16A61P31/20
CPCA61K31/4402A61K36/60A61P1/16A61P31/20A61K2300/00
Inventor 叶耀良叶笑平陈新泉
Owner GUANGDONG LUOFUSHAN SINOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com